|
|
||||||||||||||
|
|
|||||||||||||||
EDITORIAL |
1 Department of Urology, Barts & The London NHS Trust, London, UK
2 Department of Psychology, Panteion University of Social & Political Sciences, Athens, Greece
Correspondence to:
Dr A G Papatsoris, Department of Urology, Barts & The London NHS Trust, London, UK; agpapatsoris@yahoo.gr
Keywords: behaviour; prostate cancer; screening
| The first 150 words of the full text of this article appear below. |
Prostate cancer remains the most common non-cutaneous malignancy in the Western world and is the second leading cause of cancer death in males.1 The lifetime risk of developing and dying from prostate cancer rises substantially among men after the age of 50 years and a twofold greater risk exists among African–American men. Along with age and race, having a family history of prostate cancer is also a well-established risk factor. The incidence of prostate cancer has increased dramatically within the past decade, primarily due to the utilisation of serum prostate specific antigen (PSA) as a screening test that has resulted in earlier diagnosis.1 Prostate cancer screening means the examination of asymptomatic people in order to classify them according to whether they are likely or unlikely to have prostate cancer. Apart from PSA, screening includes digital rectal examination, trans-rectal ultrasound and biopsies on indication.
PROBLEMS WITH ROUTINE SCREENING
Several problems have beset the widespread acceptance
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |